SCHEMBL7428834

SCHEMBL7428834

CC(=O)c1c(C)n(Cc2ccccc2Cl)c2cc(C(N)=O)ccc12

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
L3MBTL1 Q9Y468 1/20 0.64
PLA2G2A P14555 3/20 0.48
ALOX5AP P20292 1/20 0.44
DPP4 P27487 1/20 0.44
CNR2 P34972 1/20 0.43
TP53 P04637 2/20 0.43
RXFP1 Q9HBX9 1/20 0.43
ALDH1A1 P00352 3/20 0.43
MEN1 O00255 1/20 0.43
KMT2A Q03164 1/20 0.43
MAPT P10636 2/20 0.43
LMNA P02545 1/20 0.43
GAA P10253 1/20 0.43
CYP1A2 P05177 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2D6 P10635 1/20 0.42
CYP2C9 P11712 1/20 0.42
CYP2C19 P33261 1/20 0.42
SLC22A12 Q96S37 1/20 0.42
TNF P01375 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7414196 0.90 L3MBTL1 (0.65) L3MBTL1PLA2G2AALOX5APDPP4TP53
SCHEMBL7426971 0.89 L3MBTL1 (0.51) L3MBTL1PLA2G2AALOX5APDPP4CNR2
SCHEMBL7422326 0.89 L3MBTL1 (0.51) L3MBTL1PLA2G2AALOX5APDPP4CNR2
SCHEMBL7471798 0.87 L3MBTL1 (0.48) L3MBTL1PLA2G2AALOX5APDPP4TP53
SCHEMBL7421205 0.87 L3MBTL1 (0.62) L3MBTL1PLA2G2ADPP4TP53ALDH1A1
SCHEMBL7424858 0.85 L3MBTL1 (0.47) L3MBTL1PLA2G2AALOX5APDPP4CNR2
SCHEMBL7420594 0.84 L3MBTL1 (0.47) L3MBTL1ALOX5APDPP4TP53RXFP1
SCHEMBL7421179 0.81 L3MBTL1 (0.43) L3MBTL1PLA2G2AALOX5APDPP4CNR2
SCHEMBL7426692 0.81 ALOX5AP (0.43) L3MBTL1PLA2G2AALOX5APDPP4CNR2
SCHEMBL7420966 0.80 ALOX5AP (0.44) L3MBTL1ALOX5APDPP4CNR2TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0820441-B1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO (JP) 2002-06-26 EP disclosed
US-6358992-B1 Method of inhibiting neoplastic cells with indole derivatives CELL PATHWAYS, INC. 2002-03-19 US disclosed
US-6069156-A Indole derivatives as cGMP-PDE inhibitors FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-05-30 US disclosed
WO-1996032379-A1 INDOLE DERIVATIVES AS cGMP-PDE INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-10-17 WO disclosed